MBRX
Moleculin Biotech Inc
NASDAQ: MBRX · HEALTHCARE · BIOTECHNOLOGY
$2.48
-0.40% today
Updated 2026-05-06
Market cap
$13.39M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-28.42
Dividend yield
—
52W range
$2 – $29
Volume
0.1M
Moleculin Biotech Inc (MBRX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-256.10%
ROA
-80.30%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2015 | $0.00 | $-748360.00 | — | — | — |
| 2016 | $0.00 | $-3.93M | — | — | — |
| 2017 | $9000.00 | $-9.80M | -200.00% | -96,144.44% | -108,944.44% |
| 2018 | $0.00 | $-11.88M | — | — | — |
| 2019 | $0.00 | $-13.21M | — | — | — |
| 2020 | $0.00 | $-17.36M | — | — | — |
| 2021 | $0.00 | $-15.89M | — | — | — |
| 2022 | $0.00 | $-29.02M | — | — | — |
| 2023 | $0.00 | $-29.77M | — | — | — |
| 2024 | $0.00 | $-21.76M | — | — | — |
| 2025 | $0.00 | $-33.56M | — | — | — |